Pharmacogenomics in pulmonary arterial hypertension: Toward a mechanistic, target-based approach to therapy

por Said, Sami I., Hamidi, Sayyed A.
Publicado 2011

VIP Gene Deletion in Mice Causes Cardiomyopathy Associated with Upregulation of Heart Failure Genes

por Szema, Anthony M., Hamidi, Sayyed A., Smith, S. David, Benveniste, Helene
Publicado 2013

Vasoactive Intestinal Peptide Knockout (VIP KO) mouse model of sulfite-sensitive asthma: up-regulation of novel lung carbonyl reductase

por Szema, Anthony M, Hamidi, Sayyed A, Koller, Antonius, Martin, Dwight W
Publicado 2011

VIP Regulates the Development & Proliferation of Treg in vivo in spleen

por Szema, Anthony M, Hamidi, Sayyed A, Golightly, Marc G, Rueb, Todd P, Chen, John J
Publicado 2011

VIP and endothelin receptor antagonist: An effective combination against experimental pulmonary arterial hypertension

por Hamidi, Sayyed A, Lin, Richard Z, Szema, Anthony M, Lyubsky, Sergey, Jiang, Ya Ping, Said, Sami I
Publicado 2011

NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease

por Szema, Anthony M., Forsyth, Edward, Ying, Benjamin, Hamidi, Sayyed A., Chen, John J., Hwang, Sonya, Li, Jonathan C., Sabatini Dwyer, Debra, Ramiro-Diaz, Juan M., Giermakowska, Wieslawa, Gonzalez Bosc, Laura V.
Publicado 2017